Post by Johan on Nov 5, 2024 16:56:52 GMT -4
Enhancing Immunotherapy in Hepatocellular Carcinoma (HCC) with HDAC Inhibitors, MAO-A Inhibitors, and Combination Therapies
Shen, Chen & Li, Mei & Duan, Yujuan & Jiang, Xin & Xiaoming, Hou & Xue, Fulai & Zhang, Yinan & Luo, Yao. (2023). HDAC inhibitors enhance the anti-tumor effect of immunotherapies in hepatocellular carcinoma. Frontiers in Immunology. 14. 10.3389/fimmu.2023.1170207.
Wang, YC., Wang, X., Yu, J. et al. Targeting monoamine oxidase A-regulated tumor-associated macrophage polarization for cancer immunotherapy. Nat Commun 12, 3530 (2021). doi.org/10.1038/s41467-021-23164-2
------------------------------
anticancersynergies.com/
Shen, Chen & Li, Mei & Duan, Yujuan & Jiang, Xin & Xiaoming, Hou & Xue, Fulai & Zhang, Yinan & Luo, Yao. (2023). HDAC inhibitors enhance the anti-tumor effect of immunotherapies in hepatocellular carcinoma. Frontiers in Immunology. 14. 10.3389/fimmu.2023.1170207.
Wang, YC., Wang, X., Yu, J. et al. Targeting monoamine oxidase A-regulated tumor-associated macrophage polarization for cancer immunotherapy. Nat Commun 12, 3530 (2021). doi.org/10.1038/s41467-021-23164-2
------------------------------
anticancersynergies.com/